Zurcher Kantonalbank Zurich Cantonalbank trimmed its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 42.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,823 shares of the company's stock after selling 3,520 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Addus HomeCare were worth $477,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of ADUS. Alliancebernstein L.P. boosted its stake in shares of Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after acquiring an additional 91 shares during the period. Natixis boosted its position in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the period. Heritage Family Offices LLP boosted its position in Addus HomeCare by 6.3% during the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares during the period. Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 6.3% during the first quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares during the period. Finally, Stifel Financial Corp boosted its position in Addus HomeCare by 1.2% during the fourth quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after purchasing an additional 153 shares during the period. 95.35% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on ADUS. TD Cowen lifted their price objective on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Macquarie reaffirmed an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research report on Wednesday, July 16th. Seven investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $142.86.
Read Our Latest Stock Report on Addus HomeCare
Insider Buying and Selling
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.50% of the stock is currently owned by company insiders.
Addus HomeCare Stock Performance
ADUS traded up $0.17 during trading on Tuesday, hitting $112.12. The stock had a trading volume of 22,895 shares, compared to its average volume of 192,990. The company has a 50 day moving average price of $111.74 and a 200-day moving average price of $107.59. The firm has a market cap of $2.06 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 1.68 and a beta of 0.80. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%. The firm's quarterly revenue was up 21.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.35 EPS. As a group, research analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.